Target intelligence / Profile preview

MAP3K7 C-terminal-like protein (MAP3K7CL)

Target
MAP3K7CL
Molecular classification
Other (function and family not clearly defined; not known as a canonical kinase, enzyme, receptor, ion channel, transporter, or transcription factor)
01

Overview

MAP3K7 C-terminal-like protein (MAP3K7CL) is a protein encoded by the MAP3K7CL gene on human chromosome 21. Despite its name, which implies a relationship to MAP3K7 (TAK1), the function of MAP3K7CL remains unclear, and there is little evidence it acts as a kinase or participates in well-characterized signaling pathways. It is a protein-coding gene expressed in peripheral blood leukocytes and other tissues and is listed as being associated with certain cancers (like skin sarcoma) in some gene databases, but there is no established evidence for it serving as a therapeutic target, biomarker, or having any defined molecular function or disease mechanism at this time[3][4][5][6]. Notes on ambiguity: - MAP3K7CL is not the same as MAP3K7/TAK1, which *is* a known kinase with well-characterized functions; do not confuse the two[1][2]. - Some aliases (e.g., TAK1L, TAKL) might cause confusion with MAP3K7 (TAK1), but these are distinct genes and proteins. - No evidence supports MAP3K7CL as a receptor, enzyme, or therapeutic target; no drugs or clinical guidelines reference it as such. If structured data is required, most fields—especially those relating to pharmacology or clinical relevance—should remain null due to the current lack of characterization.

Other names
MAP3K7CLC21orf7TAK1LTAKLTAKL-1TAKL-2TAKL-4MAP3K7 C-terminal-like proteinTAK1-like proteinHC21ORF7TAK1-like protein 1TAK1-like protein 2TAK1-like protein 4TGF-beta activated kinase
02

Biological functions

Unknown (function is unclear and uncharacterized)
03

Disease associations

Skin sarcoma (possibly associated)Other (no strong or direct disease associations established)

Beyond the preview

Go deeper on MAP3K7 C-terminal-like protein (MAP3K7CL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MAP3K7 C-terminal-like protein (MAP3K7CL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call